Insider Transactions by Struthers Richard Scott

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
CRNXCrinetics Pharmaceuticals, Inc.Struthers Richard ScottPresident & CEOApr 15, 2024Option Exercise$1.9120,00038,200257,835Apr 17, 2024, 04:30 PM
CRNXCrinetics Pharmaceuticals, Inc.Struthers Richard ScottPresident & CEOApr 04, 2024Sale$29.2281,9022,393,586278,786Apr 08, 2024, 05:09 PM
CRNXCrinetics Pharmaceuticals, Inc.Struthers Richard ScottPresident & CEOMar 18, 2024Option Exercise$38.1412,687483,882237,835Mar 20, 2024, 06:31 PM
CRNXCrinetics Pharmaceuticals, Inc.Struthers Richard ScottPresident & CEONov 09, 2023Option Exercise$1.9150,00095,500185,522Nov 13, 2023, 04:33 PM
CRNXCrinetics Pharmaceuticals, Inc.Struthers Richard ScottPresident & CEONov 02, 2023Option Exercise$19.621,83636,013136,440Nov 06, 2023, 06:02 PM
CRNXCrinetics Pharmaceuticals, Inc.Struthers Richard ScottPresident & CEONov 03, 2023Option Exercise$19.92398,1647,931,427334,604Nov 06, 2023, 06:02 PM
CRNXCrinetics Pharmaceuticals, Inc.Struthers Richard ScottPresident & CEOAug 14, 2023Option Exercise$1.9110,00019,100135,522Aug 16, 2023, 04:30 PM
CRNXCrinetics Pharmaceuticals, Inc.Struthers Richard ScottPresident & CEOJul 11, 2023Sale$20.1424,384491,094656,421Jul 13, 2023, 04:56 PM
CRNXCrinetics Pharmaceuticals, Inc.Struthers Richard ScottPresident & CEOJul 12, 2023Sale$20.1711,459231,128644,962Jul 13, 2023, 04:56 PM
CRNXCrinetics Pharmaceuticals, Inc.Struthers Richard ScottPresident & CEOJul 13, 2023Sale$20.3514,157288,095630,805Jul 13, 2023, 04:56 PM
CRNXCrinetics Pharmaceuticals, Inc.Struthers Richard ScottPresident & CEOJun 16, 2023Sale$20.8150,0001,040,500680,805Jun 21, 2023, 05:27 PM
CRNXCrinetics Pharmaceuticals, Inc.Struthers Richard ScottPresident & CEOMar 16, 2023Option Exercise$17.124,62879,231125,522Mar 17, 2023, 05:10 PM
CRNXCrinetics Pharmaceuticals, Inc.Struthers Richard ScottPresident & CEOOct 12, 2022Option Exercise$1.9111,10021,20168,500Oct 14, 2022, 04:55 PM
CRNXCrinetics Pharmaceuticals, Inc.Struthers Richard ScottPresident & CEOApr 13, 2022Sale$26.83138,6433,719,625844,774Apr 15, 2022, 06:00 PM
CRNXCrinetics Pharmaceuticals, Inc.Struthers Richard ScottPresident & CEOApr 05, 2022Sale$25.3421,357541,225869,448Apr 07, 2022, 05:58 PM
CRNXCrinetics Pharmaceuticals, Inc.Struthers Richard ScottPresident & CEOSep 07, 2021Sale$25.0010,000250,00090,000Sep 09, 2021, 05:00 PM
CRNXCrinetics Pharmaceuticals, Inc.Struthers Richard ScottPresident & CEOSep 07, 2021Sale$25.0010,000250,00090,000Sep 09, 2021, 05:00 PM
CRNXCrinetics Pharmaceuticals, Inc.Struthers Richard ScottPresident & CEOSep 07, 2021Sale$25.0010,000250,00090,000Sep 09, 2021, 05:00 PM
CRNXCrinetics Pharmaceuticals, Inc.Struthers Richard ScottPresident & CEODec 02, 2020Buy$12.601,00012,6001,000Dec 04, 2020, 04:59 PM
CRNXCrinetics Pharmaceuticals, Inc.Struthers Richard ScottPresident & CEODec 03, 2020Buy$13.104,00052,4004,000Dec 04, 2020, 04:59 PM
CRNXCrinetics Pharmaceuticals, Inc.Struthers Richard ScottPresident & CEOJul 15, 2020Sale$15.3017,500267,722908,305Jul 17, 2020, 05:05 PM
CRNXCrinetics Pharmaceuticals, Inc.Struthers Richard ScottPresident & CEOJul 16, 2020Sale$14.4617,500253,108890,805Jul 17, 2020, 05:05 PM
CRNXCrinetics Pharmaceuticals, Inc.Struthers Richard ScottPresident & CEOAug 05, 2019Option Exercise$1.9110,00019,1001,225,805Aug 07, 2019, 07:31 PM